Propanc Biopharma (PPCB) Non-Current Assets (2011 - 2026)
Propanc Biopharma (PPCB) recorded Non-Current Assets of $4.24 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 62.4% from $11.28 million a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Non-Current Assets (2011 - 2026) Analysis & Trends
Starting with fiscal Q4 2011, Propanc Biopharma's Non-Current Assets history includes 53 quarters.
- Annual Non-Current Assets has a five-year compound annual growth rate of 265.4% (FY2021 to FY2026).
- Across earlier fiscal years, Non-Current Assets came in at $11.28 million in FY2025, $46,924 in FY2024 (+13.6%), $41,289 in FY2023 (-38.0%) and $66,621 in FY2022 (+924.2%).
- The fiscal Q4 2026 figure is the lowest quarterly Non-Current Assets since fiscal Q2 2025.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 924.2% in fiscal Q4 2022, against a decline of 75.5% in fiscal Q1 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Propanc Biopharma | 595,565.74 | 595,565.74 | - | 4.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.24 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | 9.21 Mn |
| Jun 30, 2025 | 11.28 Mn |
| Mar 31, 2025 | 12.79 Mn |
| Dec 31, 2024 | 60,549.00 |
| Sep 30, 2024 | 42,110.00 |
| Jun 30, 2024 | 46,924.00 |
| Mar 31, 2024 | 24,482.00 |
| Dec 31, 2023 | 31,083.00 |
| Sep 30, 2023 | 34,567.00 |
| Jun 30, 2023 | 41,289.00 |
| Mar 31, 2023 | 47,167.00 |
| Dec 31, 2022 | 53,796.00 |
| Sep 30, 2022 | 56,392.00 |
| Jun 30, 2022 | 66,621.00 |
| Mar 31, 2022 | 24,954.00 |
| Dec 31, 2021 | 25,299.00 |
| Sep 30, 2021 | 5,757.00 |
| Jun 30, 2021 | 6,505.00 |
API Access
Propanc Biopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();